Fulcrum Therapeutics Inc (NQ: FULC )
9.240
-0.450
(-4.64%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
All News about Fulcrum Therapeutics Inc
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://cdn.benzinga.com/files/images/story/2023/12/22/aar_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/7a8a3a11-c9ef-4891-bab7-c5b7db91c103/small/fulcrum-logo-primary-full-color-rgb-large-copy-jpg.jpg)
![](/next-assets/images/schema-image-default.png)
Preview: Fulcrum Therapeutics's Earnings
November 06, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for Fulcrum Therapeutics
September 25, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Earnings Preview: Fulcrum Therapeutics
February 26, 2024
Via Benzinga
![](https://ml.globenewswire.com/media/7a8a3a11-c9ef-4891-bab7-c5b7db91c103/small/fulcrum-logo-primary-full-color-rgb-large-copy-jpg.jpg)
![](https://ml.globenewswire.com/media/7a8a3a11-c9ef-4891-bab7-c5b7db91c103/small/fulcrum-logo-primary-full-color-rgb-large-copy-jpg.jpg)
![](https://ml.globenewswire.com/media/7a8a3a11-c9ef-4891-bab7-c5b7db91c103/small/fulcrum-logo-primary-full-color-rgb-large-copy-jpg.jpg)
![](https://ml.globenewswire.com/media/7a8a3a11-c9ef-4891-bab7-c5b7db91c103/small/fulcrum-logo-primary-full-color-rgb-large-copy-jpg.jpg)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/7a8a3a11-c9ef-4891-bab7-c5b7db91c103/small/fulcrum-logo-primary-full-color-rgb-large-copy-jpg.jpg)
![](https://ml.globenewswire.com/media/7a8a3a11-c9ef-4891-bab7-c5b7db91c103/small/fulcrum-logo-primary-full-color-rgb-large-copy-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
September 25, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/7a8a3a11-c9ef-4891-bab7-c5b7db91c103/small/fulcrum-logo-primary-full-color-rgb-large-copy-jpg.jpg)
![](https://ml.globenewswire.com/media/7a8a3a11-c9ef-4891-bab7-c5b7db91c103/small/fulcrum-logo-primary-full-color-rgb-large-copy-jpg.jpg)
Wave of FDA Fast Track Designations Highlight Biotech Momentum Carrying into 2023
September 13, 2023
Exposures
Product Safety
![](https://ml.globenewswire.com/media/7a8a3a11-c9ef-4891-bab7-c5b7db91c103/small/fulcrum-logo-primary-full-color-rgb-large-copy-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/08/24/splunk_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/08/24/dollar_tree_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/08/23/fulc.png?width=1200&height=800&fit=crop)
Fulcrum Therapeutics To Rally Around 120%? FDA Update Removes Overhang On Pivotal Program
August 23, 2023
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/images/story/2023/08/22/dicks_sporting_goods_-_logo.jpg?width=1200&height=800&fit=crop)
Crude Oil Falls; Dick's Sporting Goods Earnings Miss Views
August 22, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 22, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For August 23, 2023
August 23, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/08/22/image48.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/08/22/macys_-_logo.jpg?width=1200&height=800&fit=crop)
Why Macy's Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
August 22, 2023
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/images/story/2023/08/22/fulc.png?width=1200&height=800&fit=crop)
Why Is Fulcrum Therapeutics Stock Surging Today?
August 22, 2023
Via Benzinga
Exposures
Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.